Company Filing History:
2 out of 4 
2 out of 1,743 
2 out of 5,072 
Years Active: 2021-2023
Title: Yannick Bessin: Innovator in ERK Kinase Inhibitors
Introduction
Yannick Bessin is a notable inventor based in Montpellier, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that act as inhibitors of ERK kinase activity.
Latest Patents
Yannick Bessin holds 2 patents related to Azaindole derivatives and their use as ERK kinase inhibitors. His latest patents include a compound of formula (I), or one of its pharmaceutically acceptable salts, specifically designed for use as inhibitors of ERK kinase activity, particularly ERK2 activity. Additionally, he has developed Zaindole derivatives that serve a similar purpose, focusing on their application as inhibitors of ERK kinase activity.
Career Highlights
Throughout his career, Yannick has worked with prominent organizations such as Agv Discovery and the Institut National de la Santé et de la Recherche Médicale. His work has been instrumental in advancing the understanding and treatment of diseases related to ERK kinase activity.
Collaborations
Yannick Bessin has collaborated with esteemed colleagues, including Jean-François Guichou and Cédric Bories, contributing to the innovative research in his field.
Conclusion
Yannick Bessin's work in developing ERK kinase inhibitors showcases his dedication to advancing medicinal chemistry. His contributions are significant in the ongoing quest for effective therapeutic solutions.